Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st
Nycomed Amersham received the Queens Award for Enterprise, which is given in recognition for a companys outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st birthday.
The companys headquarters are located in the U.K. while its North American operations are headquartered in Princeton, NJ.
The companys U.K. imaging business group won the award for its continuous achievement in export sales from 1994 to 1999. During this time, Nycomeds British exports more than doubled. Over half of Nycomeds success came through sales from the U.S. office. Myoview, a heart imaging agent, and OncoSeed, a treatment for prostate cancer, were best-sellers, said Daniel L. Peters, Nycomed Imagings U.S. president. The company has won the Queens Award 14 times in the last 33 years.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.